A Phase 1, Open-label, Fixed Sequence, 1-way Drug-drug Interaction Study to Investigate the Pharmacokinetics of GSK3036656 and an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel When the Oral Contraceptive is Administered Alone and in Combination With GSK3036656 in Healthy Female Participants of Nonchildbearing Potential Aged 18-65 Years of Age
Latest Information Update: 31 Dec 2024
At a glance
- Drugs Ganfeborole (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Tuberculosis
- Focus Pharmacokinetics
- Sponsors GSK
- 27 Dec 2024 Status changed from recruiting to completed.
- 03 May 2024 Status changed from not yet recruiting to recruiting.
- 12 Apr 2024 New trial record